相关实验视频

Updated: Sep 9, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

作为治疗癌症疫苗的树突细胞衍生的细胞外囊:机制和优化策略

Jonathan Shpigelman¹, Krishna Rao^1,2

¹Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.

|September 2, 2025

概括

细胞外囊泡 (EVs) 由于其免疫刺激性质,可以作为癌症疫苗. 然而,有限的临床成功需要提高其有效性和针对性,以获得更好的患者结果.

科学领域:

免疫学
纳米技术
癌症学

背景情况:

细胞外囊泡 (EV) 是参与细胞间通信的纳米粒子.
由于其免疫刺激载荷和抗原呈现能力,状细胞衍生的EV被探索为癌症疫苗平台.
目前基于EV的癌症疫苗面临的挑战包括不理想的免疫性,不良的向性和瘤微环境抑制.

研究的目的:

审查细胞外囊泡 (EV) 作为治疗癌症疫苗的潜力.
确定阻碍基于EV的癌症疫苗临床疗效的局限性.
探索克服这些局限性和改善临床结果的策略.

主要方法:

对基于EV的癌症疫苗进行的临床前和临床研究的文献综述.
分析EV载荷,表面受体和与免疫细胞的相互作用.
评估增强EV免疫性,向和瘤微环境调节的策略.

主要成果:

电动汽车可以传输生物活性物质和呈现抗原, 激活免疫反应.
EV癌症疫苗的临床疗效受到免疫性和向性等因素的限制.
正在制定各种策略来提高EV疫苗的性能.

结论:

细胞外囊泡对癌症疫苗的开发具有显著的前景.
通过先进的策略克服目前的局限性对于临床成功至关重要.
需要进一步的研究和优化,以充分实现基于EV的癌症疫苗的治疗潜力.

关键词:

CD8细胞癌症树突细胞接种疫苗

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.